Myocardial perfusion, oxidative metabolism, and free fatty acid uptake in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene: a positron emission tomography study.

doi:10.1016/j.nuclcard.2006.12.329

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Myocardial perfusion, oxidative metabolism, and free fatty acid uptake in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene: a positron emission tomography study.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology - 1 Jan 2000

Tuunanen Helena, Kuusisto Johanna, Toikka Jyri, Jääskeläinen Pertti, Marjamäki Päivi, Peuhkurinen Keijo, Viljanen Tapio, Sipola Petri, Stolen Kira Q, Hannukainen Jarna, Nuutila Pirjo, Laakso Markku, Knuuti Juhani

Abstract excerpt

BACKGROUND: The relationship between myocardial metabolic changes and the severity of left ventricular (LV) hypertrophy in patients with hypertrophic cardiomyopathy (HCM) is largely unknown. We characterized metabolic abnormalities in patients with a genetically identical cause for HCM but with variable LV hypertrophy. METHODS AND RESULTS: Eight patients with HCM attributable to the Asp175Asn mutation in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiomyopathy, Hypertrophic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fatty Acids, Nonesterified

Share to Genomics

Share to Myocardium

Share to Oxidation-Reduction

Share to Oxygen

Share to Positron-Emission Tomography

Share to Tropomyosin

Source

Open in PubMed

Identifiers

PMID: 17556170
DOI: 10.1016/j.nuclcard.2006.12.329

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Myocardial perfusion, oxidative metabolism, and free fatty acid uptake in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene: a positron emission tomography study.PMID 17556170Read ↗

Altered Cardiac Energetics and Mitochondrial Dysfunction in Hypertrophic Cardiomyopathy.Semantic proximity Read ↗

Cine MR imaging of myocardial contractile impairment in patients with hypertrophic cardiomyopathy attributable to Asp175Asn mutation in the alpha-tropomyosin gene.Semantic proximity Read ↗

Metabolic remodeling in hypertrophied and failing myocardium: a review.Semantic proximity Read ↗

First-pass MR imaging in the assessment of perfusion impairment in patients with hypertrophic cardiomyopathy and the Asp175Asn mutation of the alpha-tropomyosin gene.Semantic proximity Read ↗

Mutation specific impairment of fatty acid and pyruvate oxidation in hypertrophic cardiomyopathy mouse models.Semantic proximity Read ↗

Integrating Clinical Phenotype With Multiomics Analyses of Human Cardiac Tissue Unveils Divergent Metabolic Remodeling in Genotype-Positive and Genotype-Negative Patients With Hypertrophic Cardiomyopathy.Semantic proximity Read ↗

Increased Myocardial Oxygen Consumption Precedes Contractile Dysfunction in Hypertrophic Cardiomyopathy Caused by Pathogenic TNNT2 Gene Variants.Semantic proximity Read ↗

Clinical features of hypertrophic cardiomyopathy caused by mutation of a "hot spot" in the alpha-tropomyosin gene.Semantic proximity Read ↗

Myocardial Perfusion Defects in Hypertrophic Cardiomyopathy Mutation Carriers.Semantic proximity Read ↗

Integrated left ventricular multi-omics landscape of human cardiometabolic HFpEF.Semantic proximity Read ↗

Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction.Semantic proximity Read ↗

Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.